Status:

TERMINATED

Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19

Lead Sponsor:

US Biotest, Inc.

Conditions:

2019 Novel Coronavirus Infection

COVID-19 Virus Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

This trial will study the use of USB002 given as an intravenous infusion in patients with respiratory distress due to infection with COVID-19.

Eligibility Criteria

Inclusion

  • Signed informed consent from patient or legal representative;
  • Age 18 or greater;
  • Positive reverse transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2 (≤10 days);
  • Respiratory rate \> 20 RR;
  • SpO2 \< 94% on room air, requiring supplemental oxygen, requiring invasive mechanical ventilation, or requiring ECMO;
  • Chest X-ray confirming bilateral pulmonary infiltrates;
  • Body mass index of ≤ 40 units/kg/m2;
  • Adequate method of birth control.

Exclusion

  • Terminally ill patients due to underlying cardiac, cancer or severe debilitating neurological disease including coma;
  • Hospitalization expected to be \< 96 hours due to medical improvement;
  • Interstitial lung disease;
  • Correction of QTc values obtained by 12 lead EKG using Fredericia's formula (QTcF) \> 450 ms;
  • History of hypotension (mean arterial blood pressure \< 65 mmHg), unrelated to CoVID-19 infection;
  • Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \> 3 times upper limit of normal;
  • Participating concurrently on another clinical trial for the experimental treatment of COVID-19;
  • Active chemotherapy use;
  • Pregnant and/or lactating women.

Key Trial Info

Start Date :

July 27 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 10 2022

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT04778059

Start Date

July 27 2021

End Date

May 10 2022

Last Update

December 1 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Arizona Health Sciences Center/ Banner Healthcare Systems Hospitals

Tucson, Arizona, United States, 85724